Dr. Xiang Liu - May 28, 2024 - "Type I IFN Modulation by Alphavirus: Innate Immunity, Ross River Virus, and Disease Pathogenesis"


Wern Hann Ng, PhD

  • Institute for Glycomics
    Global Virus Network Centre of Excellence in Arboviruses
    Menzies Health Institute Queensland
    Griffith University

Dr. Xiang Liu is a mid-career researcher specializing in arthropod-borne and respiratory viruses. With a PhD from Griffith University's Institute for Glycomics, he currently works as a research fellow at the Menzies Health Institute Queensland. Dr. Liu's expertise lies in understanding how virus infections interact with the host immune response, particularly in human viral diseases. Notable achievements include developing a next-generation SARS-CoV-2 mucosal vaccine, now in human clinical trials. He has authored 31 peer-reviewed publications, including impactful papers in journals such as Nature Microbiology and Nature Communications, showcasing his significant contributions to molecular virology and viral immunology.